Literature DB >> 21472347

Suppression of A549 lung cancer cell migration by precursor let-7g microRNA.

Sungjin Park1, Arash Minai-Tehrani, Cheng-Xiong Xu, Seung-Hee Chang, Min-Ah Woo, Mi-Suk Noh, Eun-Sun Lee, Hwang-Tae Lim, Gil-Hwan An, Kee-Ho Lee, Ha-Jung Sung, George R Beck, Myung-Haing Cho.   

Abstract

Let-7g miRNAs, short non-coding RNAs approximately 21 nucleotides long, repress protein translation by binding to the 3'UTR of target mRNAs. Aberrant expression of let-7g is associated with the poor prognosis of lung cancer patients. Compared to normal lung cells, let-7g expression is absent in non-small cell lung cancer (NSCLC) cells. Furthermore, K-Ras and HMGA2 are well known as targets of let-7g. In this study, we evaluated the potential role of precursor (pre)-let-7g in lung cancer cell metastasis, focusing on the two targets of let-7g, HMGA2 and K-Ras. We found that pre-let-7g inhibited the migration of A549 lung cancer cells through HMGA2-mediated E2F1 down-regulation. Thus, our results suggest that pre-let-7g could be used as a suitable target for the suppression of lung cancer cell migration.

Entities:  

Year:  2010        PMID: 21472347     DOI: 10.3892/mmr.2010.373

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

1.  Quantitative proteomics reveals regulation of karyopherin subunit alpha-2 (KPNA2) and its potential novel cargo proteins in nonsmall cell lung cancer.

Authors:  Chun-I Wang; Kun-Yi Chien; Chih-Liang Wang; Hao-Ping Liu; Chia-Chen Cheng; Yu-Sun Chang; Jau-Song Yu; Chia-Jung Yu
Journal:  Mol Cell Proteomics       Date:  2012-07-25       Impact factor: 5.911

2.  The heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancer.

Authors:  Xiaowen Hu; Jinyi Guo; Lan Zheng; Chunsheng Li; Tim M Zheng; Janos L Tanyi; Shun Liang; Chiara Benedetto; Marco Mitidieri; Dionyssios Katsaros; Xia Zhao; Youcheng Zhang; Qihong Huang; Lin Zhang
Journal:  Mol Cancer Res       Date:  2013-01-21       Impact factor: 5.852

3.  MicroRNAs - Important Molecules in Lung Cancer Research.

Authors:  Petra Leidinger; Andreas Keller; Eckart Meese
Journal:  Front Genet       Date:  2012-01-23       Impact factor: 4.599

4.  Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.

Authors:  Srinivasulu Yerukala Sathipati; Shinn-Ying Ho
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

5.  Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma.

Authors:  Jongmin Sim; Yeseul Kim; Hyunsung Kim; Su-Jin Shin; Dong-Hoon Kim; Seung Sam Paik; Kiseok Jang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

Review 6.  MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.

Authors:  Maria Konoshenko; Yuriy Lansukhay; Sergey Krasilnikov; Pavel Laktionov
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.